Try all of the on-demand periods from the Clever Safety Summit here.

From generative AI purposes to healthcare and biotech, these are 5 AI startups — together with three primarily based in Israel — that made headlines over the previous week: 

1. Tome applies AI-generated textual content and pictures collectively for displays 

Tome, which calls itself the “new storytelling format for work and vital concepts” and final month built-in OpenAI’s DALL-E into its versatile, interactive slide choices, introduced this week that it has added general “generated storytelling” to the combo. That’s, with a single textual content immediate, the AI startup says creators can “generate total narratives from scratch, full with clever titles, outlines, pagination, web page layouts and web page content material supported by GPT-3 and AI-generated photographs.”

The capabilities have been launched in beta. In line with a press release, extra iterations and new AI performance, together with textual content and tone modifying, inline picture changes, and alternate layouts, are anticipated in early 2023. 

2. Jasper releases Jasper Chat to create AI-generated content material 

Dave Rogenmoser, CEO of AI content material platform Jasper — which raised $125 million in funding in October — not too long ago advised VentureBeat that generative AI “will affect each instrument on the market.” That goes for Jasper, too: This week the AI startup introduced a brand new AI chat interface utilizing pure language that enables customers to request a wide range of duties, resembling “Writing a weblog put up on…”, “Creating advert variations for…”, or making changes to mirror a extra informal tone.


Clever Safety Summit On-Demand

Study the essential function of AI & ML in cybersecurity and trade particular case research. Watch on-demand periods at this time.

Watch Here

In line with a press release, Jasper Chat is “constructed and fine-tuned for enterprise use circumstances, resembling advertising and marketing and gross sales departments … it additionally permits customers to up-vote or down-vote any outcomes, permitting Jasper to study and grow to be attuned over time.”

3. Imagen AI lands $30 million for AI-powered photograph modifying 

Tel Aviv-based Imagen AI, a number one supplier of AI-powered modifying options for skilled photographers, introduced a $30 million funding this week led by international development investor Summit Companions.

In line with a press release, the AI startup was based in July 2020 to “modernize and enhance the post-production workflow {of professional} photographers by intelligently automating picture modifying at scale.” Imagen’s AI expertise creates a person profile primarily based on a photographer’s earlier work and distinctive inventive model. The extra photographs uploaded, with extra various scenes and lighting situations, the higher the AI can seize every modifying model and precisely predict dozens of modifying parameters. The corporate says its answer can save as much as 90% of post-production time.

4. Healthcare startup Biomica snags $20 million

Israeli healthcare AI startup Biomica, a subsidiary of Evogene, Ltd., is a clinical-stage biotech firm that’s harnessing the human microbiome to create breakthrough life-science merchandise in an effort to deal with a variety of significant sicknesses. It closed a $20 million greenback funding spherical this week for its predictive biology platform that makes use of AI and large information to find out the most effective microbe strains for every affected person.

The corporate’s first therapeutic is at present present process a Part 1 trial, the place it’s being examined to reveal the impact of the intestinal microbiome on enhancing the response to most cancers therapy and facilitating anti-tumor immune exercise.

5. AI pharma startup Quris will get $9 million funding

One other Tel Aviv-based AI startup, Quris, announced it has secured an extra $9 million in seed funding — bringing its whole to $37 million. The pharmaceutical startup says it’s “the primary Bio-AI clinical-prediction platform that simulates scientific trials by leveraging a patented patient-on-chip system … [The system uses] stem-cell derived tissue and AI to simulate an actual human physique’s response to medication with out counting on time-intense, inaccurate animal-testing.”

The AI expertise, it says, higher predicts which drug candidates will safely work in people, thereby decreasing drug improvement value and period. The corporate seeks to advance its Bio-AI platform, develop its group, strengthen trade collaborations and pace its novel drug analysis.

Source link